Home
Auro Laboratories Ltd Share Price History
Auro Laboratories Ltd
BSE : 16 Apr, 2025
245.05-3.3 (-1.3%)
Prev Close
248.3
Open Price
250.0
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
4917
Today's High / Low
260.0 / 242.1
52 WK High / Low
307.2 / 156.4
Market Price of Auro Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Auro Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | 37 |
| Sales YoY Gr. | - |
| Adj EPS | 1.31 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 15.1 |
Key Financial Parameters
| Parameter | 2017 |
|---|---|
| Return on Capital Emp. % | 20.3 |
| Op. Profit Mgn % | 13.43 |
| Net Profit Mgn % | 2.22 |
| Debt to Equity % | 0.98 |
Latest Shareholding
Promoters Holdings Over Time
About Auro Laboratories Ltd
- Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
- Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
- The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
- The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
- Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.
Popular Search
FAQs for Auro Laboratories Ltd Share Price History
What are the key events that typically impact Auro Laboratories Ltd's share price history?
Key events that impact Auro Laboratories Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Auro Laboratories Ltd's share price history?
Stock splits reduce the nominal price of Auro Laboratories Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Auro Laboratories Ltd?
Dividends can influence Auro Laboratories Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Auro Laboratories Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Auro Laboratories Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Auro Laboratories Ltd’s share price history?
To understand Auro Laboratories Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
